ME NewsWire / BusinessWire
Company Able to Reallocate Portion of Total Global IT Budget with Stroke of a Pen
LAS VEGAS - Tuesday, September 3rd 2013
Rimini Street, Inc., the leading third-party maintenance and support provider for enterprise software, including SAP AG’s (NYSE: SAP) Business Suite and BusinessObjects software and Oracle Corporation’s (NYSE: ORCL) Siebel, PeopleSoft, JD Edwards, E-Business Suite, Oracle Database and Hyperion software, today announced that it has been select by The Valspar Corporation (NYSE: VAL) to support the company’s Oracle E-Business Suite 11.5.10. Choosing Rimini Street Support will enable Valspar to help generate significant savings from its annual support costs and reallocate a portion of its total global IT budget to focus on strategic growth initiatives. Like Valspar, many companies with operations around the world have turned to Rimini Street to gain control over their ERP software roadmap and significantly reduce total support costs, enabling them to fund innovative projects that drive competitive edge, while gaining improved, ultra-premium service features, including support for customizations at no additional cost.
“By partnering with Rimini Street, Valspar was able to reallocate a portion of its total global IT budget to growth initiatives with the stroke of a pen,” said Tom Grooms, vice president and chief information officer of Valspar. “Rimini Street’s total value proposition, the breadth and depth of all the expertise it brings and the willingness to help us be successful, significantly enhances our strategic capabilities as an IT function. Rimini Street’s value is not incremental – it has a multiplier effect on our operations.”
Valspar Avoids Expensive Upgrade to Oracle E-Business Suite R12, Maximizes Existing R11 Release to Support International Growth Strategy
Based in Minneapolis, Minn. with employees in more than 25 countries, Valspar is among the leading international manufacturers of paints and coatings in the world. For more than 200 years, the Fortune-ranked company has made its mark by creating high-quality functional and decorative coatings for well-known brands in a variety of industries. In recent years, the company has experienced rapid growth, making strategic acquisitions and expanding internationally to build on its global brand.
“Valspar’s current business objective is not to upgrade, but rather to continue implementing EBS 11i as we continue to grow our business globally,” added Grooms. “We find that we can manage our upgrade cycles more efficiently through the flexibility offered by Rimini Street. This gives us a big advantage in how we deploy our resources and prioritize our upgrades.”
Rimini Street Partnership Helps IT Department Drive Major Corporate Initiative
Valspar switched to Rimini Street from Oracle support in 2012, enabling the company to significantly cut its annual support costs. As the company pursued its dynamic global growth strategy, its relationship with Rimini Street expanded beyond break/fix software support into a valued partnership, which included strategic guidance and deeper business conversations. At the support level, Rimini Street also helped drive significant reductions in related support and maintenance costs by providing support for customizations, interoperability, performance and interfaces at no additional fee. Additionally, Rimini Street provides clients with a 24X7X365 premium-level service model with an assigned Primary Support Engineer (PSE) that eliminates the need for extra maintenance resources and headcount associated with inefficient, burdensome vendor support processes and policies.
“Rimini Street is pleased to be a valued partner to Valspar as it continues to implement its explosive international growth strategy and transform the coatings industry, while expanding and standardizing its Oracle E-Business Suite implementation around the world,” said Seth Ravin, CEO, Rimini Street. “With more than 660 organizations around the world already switching their support to Rimini Street, including 75 of the Fortune 500 and 16 of the global 100, Rimini Street will help our clients run their existing Oracle and SAP applications for at least a decade, while saving up to 90 percent off their total support costs. Rimini Street clients benefit from innovative, premium-level support that also enables them to reallocate resources towards initiatives that help with the bottom line.”
About The Valspar Corporation
The Valspar Corporation (NYSE: VAL) is a global leader in the paint and coatings industry. Since 1806, Valspar has been dedicated to bringing customers the latest innovations, the finest quality and the best customer service in the coatings industry. For more information, visit www.valsparglobal.com.
About Rimini Street, Inc.
Rimini Street is the leading third-party provider of enterprise software support services. The company is redefining enterprise support services with an innovative, award-winning program that enables Oracle and SAP licensees to save up to 90 percent on total support costs over a decade, including saving 50 percent on annual support fees. Clients can remain on their current software release without any required upgrades or migrations for at least 10 years. Hundreds of global, Fortune 500, midmarket, and public sector organizations from virtually all industries have selected Rimini Street as their trusted, independent support provider. To learn more, please visit www.riministreet.com or call within the USA 888-870-9692 or internationally +1 702-839-9671.
Rimini Street and the Rimini Street logo are trademarks of Rimini Street, Inc. All other company and product names may be trademarks of their respective owners. Copyright © 2013. All rights reserved.
Contacts
Rimini Street, Inc.
Alma Park, +1 323-229-7282
apark@riministreet.com
Permalink: http://www.me-newswire.net/news/8398/en
Wednesday, September 4, 2013
Tuesday, September 3, 2013
MAXON Announces Availability of CINEMA 4D Release 15
ME Newswire / Business Wire
Industry-Defining 3D Creative Toolset for Motion Graphics, Animation, Visual Effects and Visualization Workflows Highlighted at IBC2013
FRIEDRICHSDORF, Germany - Tuesday, September 3rd 2013
IBC2013
MAXON today announced immediate availability of CINEMA 4D Release 15 (R15), a milestone release of its flagship 3D motion graphics, visual effects, painting, and rendering software application. Marked by new features and powerful 3D workflow enhancements to modeling, text creation, digital sculpting, advanced rendering optimization -- including all-new network rendering capabilities -- Release 15 expresses the company’s commitment to deliver its customer community with continued innovation and the most advanced 3D creative solutions in the industry.
Ideally suited to broadcast motion graphics and visual effects artists, game developers, architects and designers seeking exceptional stability and performance, CINEMA 4D Release 15 offers spectacular image quality, unmatched integration with leading 2D compositing applications, and a straightforward, efficient and flexible interface to handle the complexities of today’s cross-collaboration production environments.
CINEMA 4D Release 15 Info
MAXON will internationally debut CINEMA 4D Release 15 next week at IBC2013, the premier annual conference and exhibition for professionals engaged in the creation, management and delivery of entertainment and news content taking place September 13-17 at the Amsterdam RAI. The MAXON Booth/Stand at IBC will be located in Hall 6, # 6.C19. [Click here for additional details on MAXON at IBC2013.]
David Lewandowski, director and animation artist (Oblivion, Tron: Legacy, Tiny Tortures, Going to the Store) states, "Release 15 is an exciting update for users of every skill level. The all-new Team Render and Bevel alone make this a must-have upgrade.”
Pricing, Availability and Upgrade Path
CINEMA 4D Release 15 is available through MAXON and its authorized dealers. Customers with an active MAXON Service Agreement (MSA) valid through September 3, 2013, will receive an automatic upgrade. Release 15 is available for both Mac OS X and Windows.
Recommended System Requirements
About CINEMA 4D
CINEMA 4D is an award-winning, 3D motion graphics toolkit acclaimed for its seamless connectivity to popular 2D motion graphics and compositing tools. Individual artists and design teams around the world rely on the professional 3D software package, as the first choice to create high-end 3D images and animations for film, television/broadcast, architecture, games, multimedia, design and engineering.
Recent high profile entertainment projects that have used CINEMA 4D for spectacular animation and visual effects sequences include a range of feature films including Pacific Rim, Iron Man 3, Oblivion, the hit game series Halo 4; the multi Emmy-award winning TV series Boardwalk Empire and Grimm; and countless broadcast campaigns, title sequences, music videos and television commercials for leading international brands.
Acclaimed as the most pipeline-friendly professional 3D package for the motion graphics market, today’s most widely recognized broadcast and television industry entities rely on CINEMA 4D including NBC, FOX, MTV, Comedy Central, NFL, National Geographic Channel, BBC, Swiss TV, Sky TV, Al Jazeera, and many others.
All trademarks contained herein are the property of their respective owners.
CINEMA 4D R15 Imagery
http://maxonexchange.de/pr/CINEMA_4D_R15/CINEMA_4D_New_in_R15_Architectural_Grass.jpg
http://maxonexchange.de/pr/CINEMA_4D_R15/CINEMA_4D_New_in_R15_Bevel.jpg
http://maxonexchange.de/pr/CINEMA_4D_R15/CINEMA_4D_New_in_R15_Sculpting.jpg
http://maxonexchange.de/pr/CINEMA_4D_R15/CINEMA_4D_New_in_R15_Typo_Tools.jpg
Contacts
MAXON
Bärbel Buck
press_de@maxon.net
+49-(0)6172-5906643
Permalink: http://www.me-newswire.net/news/8397/en
Industry-Defining 3D Creative Toolset for Motion Graphics, Animation, Visual Effects and Visualization Workflows Highlighted at IBC2013
FRIEDRICHSDORF, Germany - Tuesday, September 3rd 2013
IBC2013
MAXON today announced immediate availability of CINEMA 4D Release 15 (R15), a milestone release of its flagship 3D motion graphics, visual effects, painting, and rendering software application. Marked by new features and powerful 3D workflow enhancements to modeling, text creation, digital sculpting, advanced rendering optimization -- including all-new network rendering capabilities -- Release 15 expresses the company’s commitment to deliver its customer community with continued innovation and the most advanced 3D creative solutions in the industry.
Ideally suited to broadcast motion graphics and visual effects artists, game developers, architects and designers seeking exceptional stability and performance, CINEMA 4D Release 15 offers spectacular image quality, unmatched integration with leading 2D compositing applications, and a straightforward, efficient and flexible interface to handle the complexities of today’s cross-collaboration production environments.
CINEMA 4D Release 15 Info
MAXON will internationally debut CINEMA 4D Release 15 next week at IBC2013, the premier annual conference and exhibition for professionals engaged in the creation, management and delivery of entertainment and news content taking place September 13-17 at the Amsterdam RAI. The MAXON Booth/Stand at IBC will be located in Hall 6, # 6.C19. [Click here for additional details on MAXON at IBC2013.]
David Lewandowski, director and animation artist (Oblivion, Tron: Legacy, Tiny Tortures, Going to the Store) states, "Release 15 is an exciting update for users of every skill level. The all-new Team Render and Bevel alone make this a must-have upgrade.”
Pricing, Availability and Upgrade Path
CINEMA 4D Release 15 is available through MAXON and its authorized dealers. Customers with an active MAXON Service Agreement (MSA) valid through September 3, 2013, will receive an automatic upgrade. Release 15 is available for both Mac OS X and Windows.
Recommended System Requirements
About CINEMA 4D
CINEMA 4D is an award-winning, 3D motion graphics toolkit acclaimed for its seamless connectivity to popular 2D motion graphics and compositing tools. Individual artists and design teams around the world rely on the professional 3D software package, as the first choice to create high-end 3D images and animations for film, television/broadcast, architecture, games, multimedia, design and engineering.
Recent high profile entertainment projects that have used CINEMA 4D for spectacular animation and visual effects sequences include a range of feature films including Pacific Rim, Iron Man 3, Oblivion, the hit game series Halo 4; the multi Emmy-award winning TV series Boardwalk Empire and Grimm; and countless broadcast campaigns, title sequences, music videos and television commercials for leading international brands.
Acclaimed as the most pipeline-friendly professional 3D package for the motion graphics market, today’s most widely recognized broadcast and television industry entities rely on CINEMA 4D including NBC, FOX, MTV, Comedy Central, NFL, National Geographic Channel, BBC, Swiss TV, Sky TV, Al Jazeera, and many others.
All trademarks contained herein are the property of their respective owners.
CINEMA 4D R15 Imagery
http://maxonexchange.de/pr/CINEMA_4D_R15/CINEMA_4D_New_in_R15_Architectural_Grass.jpg
http://maxonexchange.de/pr/CINEMA_4D_R15/CINEMA_4D_New_in_R15_Bevel.jpg
http://maxonexchange.de/pr/CINEMA_4D_R15/CINEMA_4D_New_in_R15_Sculpting.jpg
http://maxonexchange.de/pr/CINEMA_4D_R15/CINEMA_4D_New_in_R15_Typo_Tools.jpg
Contacts
MAXON
Bärbel Buck
press_de@maxon.net
+49-(0)6172-5906643
Permalink: http://www.me-newswire.net/news/8397/en
Posted by
Business Daily Africa
Skandia Selects Pitney Bowes for Customer Loyalty and Analytics Solutions
STAMFORD, Conn. - Tuesday, September 3rd 2013 [ME NewsWire]
Pitney Bowes Portrait Solutions to Help Skandia Integrate, Automate, Analyze and Personalize the Company’s Multichannel Engagement with its Customers
(BUSINESS WIRE)-- Pitney Bowes (NYSE:PBI) today announced that Skandia, one of the largest independent, customer-owned banking and insurance groups in the Nordic region, has selected the Pitney Bowes Portrait solutions to help power the company’s multichannel campaign strategy. Skandia will utilize the Pitney Bowes Portrait solutions that provide greater automation and personalization of the Company’s customer communications, as well as provide customer data that is more easily analyzed, allowing marketing and sales teams to uncover new business opportunities faster and more efficiently.
Skandia selected Pitney Bowes Portrait solutions following a rigorous review with five other customer vendors primarily for its ability to integrate campaign management, inbound response and visual analytics capabilities in a single solution.
“Pitney Bowes’ Portrait solutions stood well above the rest when we closely compared them,” said Magnus Eldberg, CRM Manager, Skandia. “Pitney Bowes could deliver the completeness and range of functionality we needed to create meaningful content, manage outreach to customers and analyze results in one seamless and valuable process. The support teams at Pitney Bowes are highly responsive, flexible and easy to work with, forming a great partnership to help us deliver on our vision for customer engagement.
“Pitney Bowes also has a significant footprint in the finance sector, both regionally and globally, including several of the world’s leading banks, which is testament to the scalability and robustness of their software solutions,” he added.
Key Benefits
Improved customer cross sell and retention rates using customer analytics to target communications
Faster conversion of unknown prospects to known customers through online behavior tracking and personalization
Better customer experience through consistent and relevant offers across all channels
Shorter time to market with easy-to-use tools integrated into a single user interface
Faster time to value by linking customer communications directly with sales and service fulfillment systems
“Today’s technology-savvy, connected customers have turned the tables on marketers,” said Kieran Kilmartin, Vice President, International Marketing, Pitney Bowes Software. “Tomorrow’s successful marketing programs will be based on data-driven analytics, personalized content and agile teams. Skandia is a real leader in recognizing these trends, and we are proud to have been selected among such stiff competition to help them execute on their vision for a superior customer experience.”
For more information on the full range of the Pitney Bowes line of customer and marketing analytics software solutions, including Portrait Miner and Portrait Explorer, please visit http://www.pitneybowes.co.uk/software/customer-and-marketing-analytics/index.shtml.
Follow us @pitneybowes and connect with Pitney Bowes on LinkedIn.
About Skandia
With more than 2.2 million customers in Sweden, Norway and Denmark and more than SEK 440 billion under management, Skandia is one of the largest independent, customer-owned banking and insurance groups in the Nordic countries. As a customer-owned bank, Skandia recognizes that today’s connected customers are seeking to engage via new forms of digital content and in more personal ways.
About Pitney Bowes
Pitney Bowes provides technology solutions for small, mid-size and large firms that help them connect with customers to build loyalty and grow revenue. Many of the company’s solutions are delivered on open platforms to best organize, analyze and apply both public and proprietary data to two-way customer communications. Pitney Bowes includes direct mail, transactional mail and call center communications in its solution mix along with digital channel messaging for the Web, email and mobile applications. Pitney Bowes: Every connection is a new opportunity™. www.pb.com.
Tags: Pitney Bowes, Skandia, Banking, Insurance, Predictive Analytics, Analytics, Data, Marketing Analytics, Customer Analytics, Campaign Management, Portrait Miner, Portrait Explorer
Contacts
Pitney Bowes Contacts:
Yvonne Summers, +44 (0)1491 416748
Yvonne.summers@pb.com
Carol Wallace, 203-351-6974
Carol.wallace@pb.com
Permalink: http://www.me-newswire.net/news/8387/en
Pitney Bowes Portrait Solutions to Help Skandia Integrate, Automate, Analyze and Personalize the Company’s Multichannel Engagement with its Customers
(BUSINESS WIRE)-- Pitney Bowes (NYSE:PBI) today announced that Skandia, one of the largest independent, customer-owned banking and insurance groups in the Nordic region, has selected the Pitney Bowes Portrait solutions to help power the company’s multichannel campaign strategy. Skandia will utilize the Pitney Bowes Portrait solutions that provide greater automation and personalization of the Company’s customer communications, as well as provide customer data that is more easily analyzed, allowing marketing and sales teams to uncover new business opportunities faster and more efficiently.
Skandia selected Pitney Bowes Portrait solutions following a rigorous review with five other customer vendors primarily for its ability to integrate campaign management, inbound response and visual analytics capabilities in a single solution.
“Pitney Bowes’ Portrait solutions stood well above the rest when we closely compared them,” said Magnus Eldberg, CRM Manager, Skandia. “Pitney Bowes could deliver the completeness and range of functionality we needed to create meaningful content, manage outreach to customers and analyze results in one seamless and valuable process. The support teams at Pitney Bowes are highly responsive, flexible and easy to work with, forming a great partnership to help us deliver on our vision for customer engagement.
“Pitney Bowes also has a significant footprint in the finance sector, both regionally and globally, including several of the world’s leading banks, which is testament to the scalability and robustness of their software solutions,” he added.
Key Benefits
Improved customer cross sell and retention rates using customer analytics to target communications
Faster conversion of unknown prospects to known customers through online behavior tracking and personalization
Better customer experience through consistent and relevant offers across all channels
Shorter time to market with easy-to-use tools integrated into a single user interface
Faster time to value by linking customer communications directly with sales and service fulfillment systems
“Today’s technology-savvy, connected customers have turned the tables on marketers,” said Kieran Kilmartin, Vice President, International Marketing, Pitney Bowes Software. “Tomorrow’s successful marketing programs will be based on data-driven analytics, personalized content and agile teams. Skandia is a real leader in recognizing these trends, and we are proud to have been selected among such stiff competition to help them execute on their vision for a superior customer experience.”
For more information on the full range of the Pitney Bowes line of customer and marketing analytics software solutions, including Portrait Miner and Portrait Explorer, please visit http://www.pitneybowes.co.uk/software/customer-and-marketing-analytics/index.shtml.
Follow us @pitneybowes and connect with Pitney Bowes on LinkedIn.
About Skandia
With more than 2.2 million customers in Sweden, Norway and Denmark and more than SEK 440 billion under management, Skandia is one of the largest independent, customer-owned banking and insurance groups in the Nordic countries. As a customer-owned bank, Skandia recognizes that today’s connected customers are seeking to engage via new forms of digital content and in more personal ways.
About Pitney Bowes
Pitney Bowes provides technology solutions for small, mid-size and large firms that help them connect with customers to build loyalty and grow revenue. Many of the company’s solutions are delivered on open platforms to best organize, analyze and apply both public and proprietary data to two-way customer communications. Pitney Bowes includes direct mail, transactional mail and call center communications in its solution mix along with digital channel messaging for the Web, email and mobile applications. Pitney Bowes: Every connection is a new opportunity™. www.pb.com.
Tags: Pitney Bowes, Skandia, Banking, Insurance, Predictive Analytics, Analytics, Data, Marketing Analytics, Customer Analytics, Campaign Management, Portrait Miner, Portrait Explorer
Contacts
Pitney Bowes Contacts:
Yvonne Summers, +44 (0)1491 416748
Yvonne.summers@pb.com
Carol Wallace, 203-351-6974
Carol.wallace@pb.com
Permalink: http://www.me-newswire.net/news/8387/en
Posted by
Business Daily Africa
Pradaxa® (Dabigatran Etexilate) Drives Boehringer Ingelheim’s Innovation Promise in Cardiovascular Diseases
Boehringer Ingelheim announces new plans to expand body of evidence for Pradaxa®
INGELHEIM, Germany - Tuesday, September 3rd 2013 [ME NewsWire]
(BUSINESS WIRE)--For media outside of the US, the UK & Canada only
Boehringer Ingelheim today announces new milestones for the novel oral anticoagulant Pradaxa® (dabigatran etexilate) with over two million patient-years of experience in all licensed indications globally.1 In addition, the company confirms research currently underway for Pradaxa® in new cardiovascular patient populations, as well as robust plans to gather real-world evidence in patients with non-valvular atrial fibrillation (NVAF). These plans are the cornerstone of an initiative to expand the scientific knowledge of stroke prevention and interventional cardiology with Pradaxa®, and demonstrate Boehringer Ingelheim’s leadership and commitment to innovative solutions for patients and healthcare providers.
Initiating new research will help strengthen understanding of the safety and efficacy profile of Pradaxa®, the longest studied novel oral anticoagulant (NOAC). Since its discovery 20 years ago, Pradaxa® has been evaluated through the extensive RE-VOLUTION® clinical trial programme, which includes 10 clinical trials involving more than 40,000 patients in over 100 countries globally.2-12
“We are building upon Pradaxa®’s strong foundation in clinical research and prescribing experience to deepen our understanding of the treatment’s benefit/risk profile to address evolving patient needs and benefit the cardiovascular community as a whole,” commented Professor Klaus Dugi, Corporate Senior Vice President Medicine, Boehringer Ingelheim. “Now, we are in discussions regarding plans for important new clinical trials where we see unmet patient need. Details of these plans will be announced in the near future.”
The efficacy and safety of Pradaxa® to reduce risk of stroke and systemic embolism in patients with NVAF was established in the pivotal RE-LY® trial, one of the largest stroke prevention clinical studies ever conducted with NVAF patients.9,10 To date, Pradaxa® has also been studied in the following areas:
Prevention of venous thromboembolism (VTE) in patients undergoing elective total hip and knee replacement surgery2-5
Acute treatment of deep vein thrombosis (DVT) or primary embolism (PE)6,7
Prevention of recurrent DVT or PE8
The company recently announced it had submitted applications to U.S. and EU regulatory authorities to review Pradaxa® for use in patients with DVT and PE.
Current Pradaxa® Research Underway
Currently, there are 12 Boehringer Ingelheim-sponsored trials of Pradaxa® in progress. These include studies which investigate Pradaxa® in patients with impaired renal function, as well as paediatric patients, and studies which explore management strategies for gastrointestinal symptoms. An investigational antidote is progressing through phase I clinical research for the reversal of Pradaxa®-induced anticoagulation.13
Additionally, the company is collecting important data on the use of Pradaxa® in clinical practice with ongoing long-term study programmes and registries. The GLORIATM-AF Registry Program is set to become one of the largest worldwide registries with the objective of understanding the long-term use of oral antithrombotic therapies in the prevention of non-valvular AF-related strokes in a real-world setting. Currently, the GLORIATM-AF Registry Program is actively recruiting in 35 countries, with a planned enrolment of up to 56,000 patients worldwide. In addition, Boehringer Ingelheim is working in close collaboration with leading hospitals, insurance, healthcare research and governmental organisations in the USA to further assess the real-world clinical usage of Pradaxa®.
Current Experience with Pradaxa®
Globally, Pradaxa® is currently approved in over 100 countries for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation and primary prevention of VTE following total hip replacement or total knee replacement surgery.1,14 The extensive in-market experience of over 2 million patient-years puts Pradaxa® first among the novel oral anticoagulants.1 Since its approval in NVAF, Pradaxa® is estimated to have prevented up to 93,000 strokes in NVAF patients compared to no treatment.1 Combined experience from the clinical trials programme and real-world clinical practice establish Pradaxa® as the longest and most extensively studied novel oral anticoagulant.1
~ENDS~
Please click on the link below for ‘Notes to Editors’ and ‘References’:
http://www.boehringer-ingelheim.com/news/news_releases/press_releases/2013/03_september_2013dabigatranetexilate.html
Contacts
Boehringer Ingelheim GmbH
Sara McClelland
Corporate Communications
Media + PR
Phone: +49 6132 – 77 8271
Fax: + 49 - 6132 – 72 6601
E-mail: press@boehringer-ingelheim.com
Twitter: http://twitter.com/Boehringer
or
More information
www.boehringer-ingelheim.com
Permalink: http://www.me-newswire.net/news/8388/en
INGELHEIM, Germany - Tuesday, September 3rd 2013 [ME NewsWire]
(BUSINESS WIRE)--For media outside of the US, the UK & Canada only
Boehringer Ingelheim today announces new milestones for the novel oral anticoagulant Pradaxa® (dabigatran etexilate) with over two million patient-years of experience in all licensed indications globally.1 In addition, the company confirms research currently underway for Pradaxa® in new cardiovascular patient populations, as well as robust plans to gather real-world evidence in patients with non-valvular atrial fibrillation (NVAF). These plans are the cornerstone of an initiative to expand the scientific knowledge of stroke prevention and interventional cardiology with Pradaxa®, and demonstrate Boehringer Ingelheim’s leadership and commitment to innovative solutions for patients and healthcare providers.
Initiating new research will help strengthen understanding of the safety and efficacy profile of Pradaxa®, the longest studied novel oral anticoagulant (NOAC). Since its discovery 20 years ago, Pradaxa® has been evaluated through the extensive RE-VOLUTION® clinical trial programme, which includes 10 clinical trials involving more than 40,000 patients in over 100 countries globally.2-12
“We are building upon Pradaxa®’s strong foundation in clinical research and prescribing experience to deepen our understanding of the treatment’s benefit/risk profile to address evolving patient needs and benefit the cardiovascular community as a whole,” commented Professor Klaus Dugi, Corporate Senior Vice President Medicine, Boehringer Ingelheim. “Now, we are in discussions regarding plans for important new clinical trials where we see unmet patient need. Details of these plans will be announced in the near future.”
The efficacy and safety of Pradaxa® to reduce risk of stroke and systemic embolism in patients with NVAF was established in the pivotal RE-LY® trial, one of the largest stroke prevention clinical studies ever conducted with NVAF patients.9,10 To date, Pradaxa® has also been studied in the following areas:
Prevention of venous thromboembolism (VTE) in patients undergoing elective total hip and knee replacement surgery2-5
Acute treatment of deep vein thrombosis (DVT) or primary embolism (PE)6,7
Prevention of recurrent DVT or PE8
The company recently announced it had submitted applications to U.S. and EU regulatory authorities to review Pradaxa® for use in patients with DVT and PE.
Current Pradaxa® Research Underway
Currently, there are 12 Boehringer Ingelheim-sponsored trials of Pradaxa® in progress. These include studies which investigate Pradaxa® in patients with impaired renal function, as well as paediatric patients, and studies which explore management strategies for gastrointestinal symptoms. An investigational antidote is progressing through phase I clinical research for the reversal of Pradaxa®-induced anticoagulation.13
Additionally, the company is collecting important data on the use of Pradaxa® in clinical practice with ongoing long-term study programmes and registries. The GLORIATM-AF Registry Program is set to become one of the largest worldwide registries with the objective of understanding the long-term use of oral antithrombotic therapies in the prevention of non-valvular AF-related strokes in a real-world setting. Currently, the GLORIATM-AF Registry Program is actively recruiting in 35 countries, with a planned enrolment of up to 56,000 patients worldwide. In addition, Boehringer Ingelheim is working in close collaboration with leading hospitals, insurance, healthcare research and governmental organisations in the USA to further assess the real-world clinical usage of Pradaxa®.
Current Experience with Pradaxa®
Globally, Pradaxa® is currently approved in over 100 countries for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation and primary prevention of VTE following total hip replacement or total knee replacement surgery.1,14 The extensive in-market experience of over 2 million patient-years puts Pradaxa® first among the novel oral anticoagulants.1 Since its approval in NVAF, Pradaxa® is estimated to have prevented up to 93,000 strokes in NVAF patients compared to no treatment.1 Combined experience from the clinical trials programme and real-world clinical practice establish Pradaxa® as the longest and most extensively studied novel oral anticoagulant.1
~ENDS~
Please click on the link below for ‘Notes to Editors’ and ‘References’:
http://www.boehringer-ingelheim.com/news/news_releases/press_releases/2013/03_september_2013dabigatranetexilate.html
Contacts
Boehringer Ingelheim GmbH
Sara McClelland
Corporate Communications
Media + PR
Phone: +49 6132 – 77 8271
Fax: + 49 - 6132 – 72 6601
E-mail: press@boehringer-ingelheim.com
Twitter: http://twitter.com/Boehringer
or
More information
www.boehringer-ingelheim.com
Permalink: http://www.me-newswire.net/news/8388/en
Posted by
Business Daily Africa
Monday, September 2, 2013
IntegenX to Present Significant Advances in Rapid DNA Technology at the 25th World Congress of the International Society of Forensic Genetics (ISFG)
PLEASANTON, Calif. - Tuesday, September 3rd 2013 [ME NewsWire]
The RapidHIT System is the world’s first rapid DNA technology to complete developmental validation in accordance with SWGDAM guidelines, and achieve full global commercial launch
(BUSINESS WIRE)-- IntegenX Inc., the leading developer of rapid human DNA identification technology, today announced that it has completed developmental validation for the RapidHIT™ System, the first fully automated, fully integrated rapid human DNA identification system. Data will be presented at the 25th World Congress of the International Society of Forensic Genetics in Melbourne, Australia, September 2-7, 2013.
Completion of SWGDAM (Scientific Working Group for DNA Analysis Methods) developmental validation is a key milestone necessary for the full commercialization of DNA technologies for the purposes of human identification in forensics, law enforcement, defense, homeland security, and intelligence community applications. In addition to developmental validation data including highly successful CODIS profile generation, IntegenX will present data on the use of the RapidHIT System to analyze samples routinely recovered from crime scenes, such as blood and saliva. These applications dramatically expand the utility of the RapidHIT System for use in crime scene investigation and rapid lead identification by law enforcement, defense, and the intelligence community. The ability to rapidly generate DNA profiles on a variety of biological samples fundamentally changes the way investigations are conducted by enabling forensics and law enforcement personnel to quickly link a suspect’s DNA to a crime scene, or eliminate suspicion, all while the suspect is still in custody.
“The completion of a developmental validation study by the manufacturer is a critical important step toward establishing rapid DNA technology as reliable and robust. Rapid DNA technology will enable both forensic and law enforcement professionals to expand the use of DNA typing as a tool to solve crimes,” said Dr. Bruce Budowle, Professor, Executive Director of the Institute of Applied Genetics at the University of North Texas Health Science Center.
“We’re thrilled at the full commercial launch of the RapidHIT System, and the significant validation dataset we have been able to generate. We look forward to helping communities and governments throughout the world implement such a game changing technology,” commented Robert Schueren, President and Chief Executive Officer of IntegenX.
The IntegenX RapidHIT System fully automates and integrates all steps necessary to generate a DNA profile in approximately 90 minutes. With less than five minutes of hands-on time, a user can generate up to five complete DNA profiles, as well as a positive and negative control. DNA profiles generated by the RapidHIT System are compatible with standard databases that contain previously generated profiles from reference and crime scene sources. Combining ease of use and rapid turnaround time for DNA results will have a high impact toward ensuring the safety of our communities.
About IntegenX Inc.
IntegenX, headquartered in Pleasanton, California, is a leading developer of rapid human DNA identification technology. IntegenX technology platforms are the result of the integration of advanced fluidics, optics, and biochemistry capabilities to produce sample-to-answer products for DNA-based human identity testing, forensics, and biodefense applications. For more information, please visit www.integenx.com.
IntegenX, the IntegenX logo, and RapidHIT are trademarks of IntegenX Inc. All other names or trademarks are the property of their respective owners.
Contacts
IntegenX Inc.
David V. Smith
Chief Operating Officer
925-701-3400
The RapidHIT System is the world’s first rapid DNA technology to complete developmental validation in accordance with SWGDAM guidelines, and achieve full global commercial launch
(BUSINESS WIRE)-- IntegenX Inc., the leading developer of rapid human DNA identification technology, today announced that it has completed developmental validation for the RapidHIT™ System, the first fully automated, fully integrated rapid human DNA identification system. Data will be presented at the 25th World Congress of the International Society of Forensic Genetics in Melbourne, Australia, September 2-7, 2013.
Completion of SWGDAM (Scientific Working Group for DNA Analysis Methods) developmental validation is a key milestone necessary for the full commercialization of DNA technologies for the purposes of human identification in forensics, law enforcement, defense, homeland security, and intelligence community applications. In addition to developmental validation data including highly successful CODIS profile generation, IntegenX will present data on the use of the RapidHIT System to analyze samples routinely recovered from crime scenes, such as blood and saliva. These applications dramatically expand the utility of the RapidHIT System for use in crime scene investigation and rapid lead identification by law enforcement, defense, and the intelligence community. The ability to rapidly generate DNA profiles on a variety of biological samples fundamentally changes the way investigations are conducted by enabling forensics and law enforcement personnel to quickly link a suspect’s DNA to a crime scene, or eliminate suspicion, all while the suspect is still in custody.
“The completion of a developmental validation study by the manufacturer is a critical important step toward establishing rapid DNA technology as reliable and robust. Rapid DNA technology will enable both forensic and law enforcement professionals to expand the use of DNA typing as a tool to solve crimes,” said Dr. Bruce Budowle, Professor, Executive Director of the Institute of Applied Genetics at the University of North Texas Health Science Center.
“We’re thrilled at the full commercial launch of the RapidHIT System, and the significant validation dataset we have been able to generate. We look forward to helping communities and governments throughout the world implement such a game changing technology,” commented Robert Schueren, President and Chief Executive Officer of IntegenX.
The IntegenX RapidHIT System fully automates and integrates all steps necessary to generate a DNA profile in approximately 90 minutes. With less than five minutes of hands-on time, a user can generate up to five complete DNA profiles, as well as a positive and negative control. DNA profiles generated by the RapidHIT System are compatible with standard databases that contain previously generated profiles from reference and crime scene sources. Combining ease of use and rapid turnaround time for DNA results will have a high impact toward ensuring the safety of our communities.
About IntegenX Inc.
IntegenX, headquartered in Pleasanton, California, is a leading developer of rapid human DNA identification technology. IntegenX technology platforms are the result of the integration of advanced fluidics, optics, and biochemistry capabilities to produce sample-to-answer products for DNA-based human identity testing, forensics, and biodefense applications. For more information, please visit www.integenx.com.
IntegenX, the IntegenX logo, and RapidHIT are trademarks of IntegenX Inc. All other names or trademarks are the property of their respective owners.
Contacts
IntegenX Inc.
David V. Smith
Chief Operating Officer
925-701-3400
Posted by
Business Daily Africa
AGCO Names New Senior Vice President & General Manager Europe, Africa and Middle East
DULUTH, Ga. - Monday, September 2nd 2013 [ME NewsWire]
(BUSINESS WIRE) AGCO, Your Agriculture Company (NYSE: AGCO), a worldwide manufacturer and distributor of agricultural equipment, today appointed Dr. Rob Smith as Senior Vice President & General Manager Europe, Africa and Middle East (EAME). “We are very pleased to announce that Rob Smith has joined our executive team,” said Martin Richenhagen, Chairman, President and Chief Executive Officer of AGCO. “Rob’s international background and extensive experience in the automotive industry make him a great addition to our management team. He will lead our strategic growth plans for EAME and build a strong market position in emerging markets including Eastern Europe and Africa.”
Dr. Smith has extensive international management experience and most recently was the Vice President & General Manager of the global Engine Components Division for TRW Automotive – one of the world’s largest automotive suppliers. He also served as the Chairman of the Supervisory Board of TRW Automotive GmbH. Prior to this, Rob served as Vice President of the Global Automotive Division at Tyco Electronics, and Vice President & General Manager of Bombardier Transportation's Aftermarket Parts and Material Repair and Overhaul business. Between 1993 and 2001, he worked in various operations and supply chain roles in the global automotive industry with LucasVarity PLC, Lucas Industries PLC and BMW.
Dr. Smith was a Combat Engineering Officer in the United States Army. He earned his Bachelor of Science in Engineering from Princeton University followed by an MBA from the University of Texas at Austin Graduate School of Business. He received German Diplom-Kaufmann and Doctoral degrees in International Operations Management from the WHU – Graduate School of Management in Koblenz, Germany. Dr. Smith is a member of the American Chamber of Commerce Board of Directors in Germany.
ABOUT AGCO
AGCO, Your Agriculture Company, (NYSE: AGCO), is a global leader focused on the design, manufacture and distribution of agricultural machinery. AGCO supports more productive farming through a full line of tractors, combines, hay tools, sprayers, forage equipment, tillage, implements, grain storage and protein production systems, as well as related replacement parts. AGCO products are sold through five core machinery brands, Challenger®, Fendt®, GSI®, Massey Ferguson® and Valtra® and are distributed globally through 3,150 independent dealers and distributors in more than 140 countries worldwide. Founded in 1990, AGCO is headquartered in Duluth, GA, USA. In 2012, AGCO had net sales of $10 billion. www.AGCOcorp.com
Contacts
AGCO
Press:
Rebecca Fabian, +1-646-415-8518
rf@stockheim-media.com
Investors:
Greg Peterson, +1-770-232-8229
greg.peterson@agcocorp.com
Permalink: http://www.me-newswire.net/news/8385/en
(BUSINESS WIRE) AGCO, Your Agriculture Company (NYSE: AGCO), a worldwide manufacturer and distributor of agricultural equipment, today appointed Dr. Rob Smith as Senior Vice President & General Manager Europe, Africa and Middle East (EAME). “We are very pleased to announce that Rob Smith has joined our executive team,” said Martin Richenhagen, Chairman, President and Chief Executive Officer of AGCO. “Rob’s international background and extensive experience in the automotive industry make him a great addition to our management team. He will lead our strategic growth plans for EAME and build a strong market position in emerging markets including Eastern Europe and Africa.”
Dr. Smith has extensive international management experience and most recently was the Vice President & General Manager of the global Engine Components Division for TRW Automotive – one of the world’s largest automotive suppliers. He also served as the Chairman of the Supervisory Board of TRW Automotive GmbH. Prior to this, Rob served as Vice President of the Global Automotive Division at Tyco Electronics, and Vice President & General Manager of Bombardier Transportation's Aftermarket Parts and Material Repair and Overhaul business. Between 1993 and 2001, he worked in various operations and supply chain roles in the global automotive industry with LucasVarity PLC, Lucas Industries PLC and BMW.
Dr. Smith was a Combat Engineering Officer in the United States Army. He earned his Bachelor of Science in Engineering from Princeton University followed by an MBA from the University of Texas at Austin Graduate School of Business. He received German Diplom-Kaufmann and Doctoral degrees in International Operations Management from the WHU – Graduate School of Management in Koblenz, Germany. Dr. Smith is a member of the American Chamber of Commerce Board of Directors in Germany.
ABOUT AGCO
AGCO, Your Agriculture Company, (NYSE: AGCO), is a global leader focused on the design, manufacture and distribution of agricultural machinery. AGCO supports more productive farming through a full line of tractors, combines, hay tools, sprayers, forage equipment, tillage, implements, grain storage and protein production systems, as well as related replacement parts. AGCO products are sold through five core machinery brands, Challenger®, Fendt®, GSI®, Massey Ferguson® and Valtra® and are distributed globally through 3,150 independent dealers and distributors in more than 140 countries worldwide. Founded in 1990, AGCO is headquartered in Duluth, GA, USA. In 2012, AGCO had net sales of $10 billion. www.AGCOcorp.com
Contacts
AGCO
Press:
Rebecca Fabian, +1-646-415-8518
rf@stockheim-media.com
Investors:
Greg Peterson, +1-770-232-8229
greg.peterson@agcocorp.com
Permalink: http://www.me-newswire.net/news/8385/en
Posted by
Business Daily Africa
Sunday, September 1, 2013
Cooper Tire Stockholders to Vote September 30 on Acquisition by Apollo Tyres
Cooper and Apollo merger on track to close after receiving U.S. and foreign regulatory clearance
FINDLAY, Ohio - Saturday, August 31st 2013 [ME NewsWire]
(BUSINESS WIRE)-- Cooper Tire & Rubber Company (NYSE: CTB) today announced it has filed a definitive proxy statement with the U.S. Securities and Exchange Commission and scheduled a special meeting of stockholders for September 30, 2013 at 10 a.m. Eastern to consider and vote on the previously announced merger with a subsidiary of Apollo Tyres Ltd (NSE: ApolloTYRE).
Cooper stockholders of record as of the close of business August 30, 2013 are entitled to vote at the special meeting, which will take place at the law offices of Jones Day, 901 Lakeside Ave., North Point, Cleveland, Ohio 44114.
Cooper Chairman, Chief Executive Officer and President Roy Armes said, “Having already received the U.S. and foreign regulatory clearance necessary to close the transaction, we are pleased to announce another step toward finalizing the merger with Apollo Tyres. When completed, the transaction will join two great companies to create a global leader in tire manufacturing and distribution. Our combined company will offer customers a comprehensive portfolio of products and brands in the world’s largest tire market of North America as well as the fastest growing geographies of China and India, among others. We are pleased the transaction continues to move forward to closing.”
Cooper and Apollo announced the proposed acquisition June 12, 2013 following unanimous approval by the boards of directors of both companies.
About Cooper Tire & Rubber Company
Cooper Tire & Rubber Company (NYSE: CTB) the parent company of a global family of companies that specialize in the design, manufacture, marketing, and sales of passenger car and light truck tires. Cooper has joint ventures, affiliates and subsidiaries that also specialize in medium truck, motorcycle and racing tires. Cooper's headquarters is in Findlay, Ohio, with manufacturing, sales, distribution, technical and design facilities within its family of companies located in 11 countries around the world. For more information on Cooper Tire, visit www.coopertire.com, www.facebook.com/coopertire or www.twitter.com/coopertire.
ADDITIONAL INFORMATION
In connection with the proposed transaction, Cooper has filed a proxy statement with the SEC. INVESTORS ARE URGED TO READ THE PROXY STATEMENT BECAUSE IT CONTAINS IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION AND COOPER. You will be able to obtain the proxy statement, as well as other filings containing information about Cooper, free of charge, at the website maintained by the SEC at www.sec.gov. Copies of the proxy statement and other filings made by Cooper with the SEC can also be obtained, free of charge, by directing a request to Cooper Tire & Rubber Company, 701 Lima Avenue, Findlay, Ohio 45840, c/o Steve Schroeder (investorrelations@coopertire.com).
Participants in the Solicitation
Cooper and its directors and officers may be deemed to be participants in the solicitation of proxies from Cooper’s stockholders with respect to the special meeting of stockholders that will be held to consider the proposed transaction. Information about Cooper’s directors and officers and their ownership of Cooper’s common stock is set forth in its Form 10-K which was filed with the SEC on February 25, 2013 and the proxy statement for Cooper’s Annual Meeting of stockholders, which was filed with the SEC on March 26, 2013. Stockholders may obtain additional information regarding the interests of Cooper and its directors and executive officers in the proposed transaction, which may be different than those of Cooper’s stockholders generally, by reading the proxy statement and other relevant documents regarding the proposed transaction.
FORWARD-LOOKING STATEMENTS
This release contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements are not based on historical facts but instead reflect Cooper’s and Apollo’s expectations, estimates or projections concerning future results or events. These statements generally can be identified by the use of forward-looking words or phrases such as “believe,” “expect,” “anticipate,” “project,” “may,” “could,” “intend,” “intent,” “belief,” “estimate,” “plan,” “likely,” “will,” “should” or similar words or phrases. These statements are not guarantees of performance and are inherently subject to known and unknown risks, uncertainties and assumptions that are difficult to predict and could cause our actual results, performance or achievements to differ materially from those expressed or indicated by those statements. We cannot assure you that any of our expectations, estimates or projections will be achieved.
The forward-looking statements included in this release are only made as of the date of this document and we disclaim any obligation to publicly update any forward-looking statement to reflect subsequent events or circumstances.
Numerous factors could cause our actual results and events to differ materially from those expressed or implied by forward-looking statements, including, without limitation: volatility in raw material and energy prices, including those of rubber, steel, petroleum based products and natural gas and the unavailability of such raw materials or energy sources; the failure of Cooper’s or Apollo’s suppliers to timely deliver products in accordance with contract specifications; changes in economic and business conditions in the world; failure to implement information technologies or related systems, including failure by Cooper to successfully implement an ERP system; increased competitive activity including actions by larger competitors or lower-cost producers; the failure to achieve expected sales levels; changes in Cooper’s or Apollo’s customer relationships, including loss of particular business for competitive or other reasons; litigation brought against Cooper or Apollo, including products liability claims, which could result in material damages against Cooper or Apollo; changes to tariffs or the imposition of new tariffs or trade restrictions; changes in pension expense and/or funding resulting from investment performance of Cooper’s pension plan assets and changes in discount rate, salary increase rate, and expected return on plan assets assumptions, or changes to related accounting regulations; government regulatory and legislative initiatives including environmental and healthcare matters; volatility in the capital and financial markets or changes to the credit markets and/or access to those markets; changes in interest or foreign exchange rates; an adverse change in Cooper’s or Apollo’s credit ratings, which could increase borrowing costs and/or hamper access to the credit markets; the risks associated with doing business outside of the United States; the failure to develop technologies, processes or products needed to support consumer demand; technology advancements; the inability to recover the costs to develop and test new products or processes; the impact of labor problems, including labor disruptions at Cooper or Apollo or at one or more of their large customers or suppliers; failure to attract or retain key personnel; consolidation among competitors or customers; inaccurate assumptions used in developing Cooper’s or Apollo’s strategic plan or operating plans or the inability or failure to successfully implement such plans; failure to successfully integrate acquisitions into operations or their related financings may impact liquidity and capital resources; changes in Cooper’s relationship with joint-venture partners; the inability to obtain and maintain price increases to offset higher production or material costs; inability to adequately protect Cooper’s or Apollo’s intellectual property rights; inability to use deferred tax assets; other factors that are set forth in management’s discussion and analysis of Cooper’s most recently filed reports with the SEC; and uncertainties associated with the proposed acquisition of Cooper by Apollo, including uncertainties relating to the anticipated timing of filings and approvals relating to the transaction, the expected timing of completion of the transaction and the ability to complete the transaction. This list of factors is illustrative, but by no means exhaustive. All forward-looking statements should be evaluated with the understanding of their inherent uncertainty.
Contacts
Cooper Tire & Rubber Company
Media Contact:
Anne Roman, +1-419-429-7189
alroman@coopertire.com
Investor Contact:
Steve Schroeder, +1-419-424-4165
investorrelations@coopertire.com
Permalink: http://www.me-newswire.net/news/8370/en
FINDLAY, Ohio - Saturday, August 31st 2013 [ME NewsWire]
(BUSINESS WIRE)-- Cooper Tire & Rubber Company (NYSE: CTB) today announced it has filed a definitive proxy statement with the U.S. Securities and Exchange Commission and scheduled a special meeting of stockholders for September 30, 2013 at 10 a.m. Eastern to consider and vote on the previously announced merger with a subsidiary of Apollo Tyres Ltd (NSE: ApolloTYRE).
Cooper stockholders of record as of the close of business August 30, 2013 are entitled to vote at the special meeting, which will take place at the law offices of Jones Day, 901 Lakeside Ave., North Point, Cleveland, Ohio 44114.
Cooper Chairman, Chief Executive Officer and President Roy Armes said, “Having already received the U.S. and foreign regulatory clearance necessary to close the transaction, we are pleased to announce another step toward finalizing the merger with Apollo Tyres. When completed, the transaction will join two great companies to create a global leader in tire manufacturing and distribution. Our combined company will offer customers a comprehensive portfolio of products and brands in the world’s largest tire market of North America as well as the fastest growing geographies of China and India, among others. We are pleased the transaction continues to move forward to closing.”
Cooper and Apollo announced the proposed acquisition June 12, 2013 following unanimous approval by the boards of directors of both companies.
About Cooper Tire & Rubber Company
Cooper Tire & Rubber Company (NYSE: CTB) the parent company of a global family of companies that specialize in the design, manufacture, marketing, and sales of passenger car and light truck tires. Cooper has joint ventures, affiliates and subsidiaries that also specialize in medium truck, motorcycle and racing tires. Cooper's headquarters is in Findlay, Ohio, with manufacturing, sales, distribution, technical and design facilities within its family of companies located in 11 countries around the world. For more information on Cooper Tire, visit www.coopertire.com, www.facebook.com/coopertire or www.twitter.com/coopertire.
ADDITIONAL INFORMATION
In connection with the proposed transaction, Cooper has filed a proxy statement with the SEC. INVESTORS ARE URGED TO READ THE PROXY STATEMENT BECAUSE IT CONTAINS IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION AND COOPER. You will be able to obtain the proxy statement, as well as other filings containing information about Cooper, free of charge, at the website maintained by the SEC at www.sec.gov. Copies of the proxy statement and other filings made by Cooper with the SEC can also be obtained, free of charge, by directing a request to Cooper Tire & Rubber Company, 701 Lima Avenue, Findlay, Ohio 45840, c/o Steve Schroeder (investorrelations@coopertire.com).
Participants in the Solicitation
Cooper and its directors and officers may be deemed to be participants in the solicitation of proxies from Cooper’s stockholders with respect to the special meeting of stockholders that will be held to consider the proposed transaction. Information about Cooper’s directors and officers and their ownership of Cooper’s common stock is set forth in its Form 10-K which was filed with the SEC on February 25, 2013 and the proxy statement for Cooper’s Annual Meeting of stockholders, which was filed with the SEC on March 26, 2013. Stockholders may obtain additional information regarding the interests of Cooper and its directors and executive officers in the proposed transaction, which may be different than those of Cooper’s stockholders generally, by reading the proxy statement and other relevant documents regarding the proposed transaction.
FORWARD-LOOKING STATEMENTS
This release contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements are not based on historical facts but instead reflect Cooper’s and Apollo’s expectations, estimates or projections concerning future results or events. These statements generally can be identified by the use of forward-looking words or phrases such as “believe,” “expect,” “anticipate,” “project,” “may,” “could,” “intend,” “intent,” “belief,” “estimate,” “plan,” “likely,” “will,” “should” or similar words or phrases. These statements are not guarantees of performance and are inherently subject to known and unknown risks, uncertainties and assumptions that are difficult to predict and could cause our actual results, performance or achievements to differ materially from those expressed or indicated by those statements. We cannot assure you that any of our expectations, estimates or projections will be achieved.
The forward-looking statements included in this release are only made as of the date of this document and we disclaim any obligation to publicly update any forward-looking statement to reflect subsequent events or circumstances.
Numerous factors could cause our actual results and events to differ materially from those expressed or implied by forward-looking statements, including, without limitation: volatility in raw material and energy prices, including those of rubber, steel, petroleum based products and natural gas and the unavailability of such raw materials or energy sources; the failure of Cooper’s or Apollo’s suppliers to timely deliver products in accordance with contract specifications; changes in economic and business conditions in the world; failure to implement information technologies or related systems, including failure by Cooper to successfully implement an ERP system; increased competitive activity including actions by larger competitors or lower-cost producers; the failure to achieve expected sales levels; changes in Cooper’s or Apollo’s customer relationships, including loss of particular business for competitive or other reasons; litigation brought against Cooper or Apollo, including products liability claims, which could result in material damages against Cooper or Apollo; changes to tariffs or the imposition of new tariffs or trade restrictions; changes in pension expense and/or funding resulting from investment performance of Cooper’s pension plan assets and changes in discount rate, salary increase rate, and expected return on plan assets assumptions, or changes to related accounting regulations; government regulatory and legislative initiatives including environmental and healthcare matters; volatility in the capital and financial markets or changes to the credit markets and/or access to those markets; changes in interest or foreign exchange rates; an adverse change in Cooper’s or Apollo’s credit ratings, which could increase borrowing costs and/or hamper access to the credit markets; the risks associated with doing business outside of the United States; the failure to develop technologies, processes or products needed to support consumer demand; technology advancements; the inability to recover the costs to develop and test new products or processes; the impact of labor problems, including labor disruptions at Cooper or Apollo or at one or more of their large customers or suppliers; failure to attract or retain key personnel; consolidation among competitors or customers; inaccurate assumptions used in developing Cooper’s or Apollo’s strategic plan or operating plans or the inability or failure to successfully implement such plans; failure to successfully integrate acquisitions into operations or their related financings may impact liquidity and capital resources; changes in Cooper’s relationship with joint-venture partners; the inability to obtain and maintain price increases to offset higher production or material costs; inability to adequately protect Cooper’s or Apollo’s intellectual property rights; inability to use deferred tax assets; other factors that are set forth in management’s discussion and analysis of Cooper’s most recently filed reports with the SEC; and uncertainties associated with the proposed acquisition of Cooper by Apollo, including uncertainties relating to the anticipated timing of filings and approvals relating to the transaction, the expected timing of completion of the transaction and the ability to complete the transaction. This list of factors is illustrative, but by no means exhaustive. All forward-looking statements should be evaluated with the understanding of their inherent uncertainty.
Contacts
Cooper Tire & Rubber Company
Media Contact:
Anne Roman, +1-419-429-7189
alroman@coopertire.com
Investor Contact:
Steve Schroeder, +1-419-424-4165
investorrelations@coopertire.com
Permalink: http://www.me-newswire.net/news/8370/en
Posted by
Business Daily Africa
Subscribe to:
Posts (Atom)